Table 4 Secondary endpoints

− Serious and non-serious adverse events

− Access technical success (i.e. procedure successfully completed with bilateral percutaneous access)

− Treatment success (i.e. successful completion of least invasive protocol through discharge)

− Blood loss, including if transfusion required

− Percent of procedures completed without general anesthesia

− Anesthesia time

− Procedure time

− Contrast volume

− Fluoroscopy time

− Time to hemostasis

− Time to ambulation

− Time to normal diet

− Groin pain

− Quality of life

− Percent of subjects discharged without ICU admission

− Length of ICU stay, if required

− Length of hospital stay

− Percent of subjects discharged within only one overnight stay

− Freedom from type I & III endoleak

− Freedom from AAA rupture

− Freedom from conversion to open repair

− Freedom from AAA-related secondary interventions

− Freedom from mortality